IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
about
Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiationEmerging regulators of the inflammatory process in osteoarthritisThe role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritisCellular functions of tissue transglutaminaseRole of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytesGenomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis.Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development.Immunopathogenesis of osteoarthritisHuman osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro.Signaling pathways in cartilage repair.Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal pNF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragmentsMicroarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy.Biological aspects of early osteoarthritis.Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.Cytokine and chemokine gene expression of IL-1beta stimulated equine articular chondrocytes.Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.S100A11: diverse function and pathology corresponding to different target proteins.Role of NF-κB in the skeletonScientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint healthRNA Microarray Analysis of Macroscopically Normal Articular Cartilage from Knees Undergoing Partial Medial Meniscectomy: Potential Prediction of the Risk for Developing Osteoarthritis.Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis.Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis.The role of chemokines in rheumatoid arthritis and osteoarthritis.Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cellsThe pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuliThe Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries.Proteomic profiling and functional characterization of early and late shoulder osteoarthritis.The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc.NF-kappaB signaling: multiple angles to target OA.Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis.Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue.Joint injury and osteoarthritis: soluble mediators in the course and treatment of cartilage pathology.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.HDACi: molecular mechanisms and therapeutic implications in the innate immune system.Transglutaminase 2 as a biomarker of osteoarthritis: an update.Biomineralization--an active or passive process?
P2860
Q26777901-619704F6-BDCA-486A-B6DE-B4F626AFCC44Q26829840-059EA3E5-EC16-45F8-B3F5-A3D4C4318525Q27011498-758CF601-9592-40E7-B5E1-90ED125EF3B5Q28260600-81F9A12E-7378-4D92-8979-317B39B996FDQ28301831-11337C1C-2D78-4060-A35B-0B9F5842D82DQ28655057-469E3FA8-BD3F-43DA-997A-9C47C9F6182CQ30855449-C94F530E-786B-4F18-8F8D-18E922107D1EQ33289555-1CA4A3F4-E5D3-4D75-B30F-4A373E83FE86Q33587966-71056A78-019F-4A45-B6DA-F95E812F43F9Q33599833-011C400B-CEB3-4383-8A64-2F898B60E8AFQ33755839-01A93364-F8A0-41E5-BC91-246F763CB3B2Q33987148-1ED8B13C-414F-4453-800D-B2B7504128A2Q33992822-5D03FBA6-7118-4CEE-9166-3B5B6F713C4CQ34099564-C7F26384-61D3-40C6-A3E2-D37CB22BB9BCQ34225355-0AEFB2AB-356C-4317-9DD0-DE8B0C4F28FBQ34605944-EBDD9EB0-87F9-4334-A3A5-F001096DDDFCQ34623168-1529AAEF-F970-4E7B-90CB-BF16173897B9Q34790159-DDA3E5F4-99F4-45A9-9760-14496622F9FDQ34995287-01D24AF2-CE51-44ED-9A14-A615A205B009Q35347883-A385E87D-811F-4F8F-A65F-3C931AC31F8FQ35933890-B370FB9B-5419-484C-A1E0-BB3A775A458EQ36015312-638AE196-7520-4DA4-9988-83159826DA66Q36111296-DDFDC62F-BDCA-4C6C-BABF-5433EB401CE6Q36263516-8E2D5711-82DE-48CC-B74D-EE63B7810183Q36360715-5892CD92-D5F9-4A9D-926C-48977BA611F5Q36959741-3B77F83B-98C7-4162-8EFA-AA1EF34120EDQ37021518-D98DF833-AF9B-4F18-AC2C-37118E87EBE8Q37119705-786EF031-15B0-476F-9F95-EF154A7940B3Q37231824-4F147383-A1AF-47B0-9149-2695EE72A429Q37342796-E36C30D9-2149-4C98-832B-24F3E2DE20E0Q37691017-66FE403A-DC26-4475-BFB6-F04DECC0DFB0Q37691242-57695910-6CF8-4FD7-A5AD-D9F5743C170BQ37701897-0FDA0910-215C-488C-B2F4-C46A28367311Q37706611-FC763DF4-9A28-45A7-85CC-27188A2A261FQ37721188-C73F9FDF-A005-4C10-8A05-7373F3569BA9Q37773271-E67B84EF-2512-443A-A56B-2108ED27587DQ37899674-F56ACFCF-A134-4C15-9C09-5FE84DFC4AB3Q37956176-76FDF407-C2A3-42DF-8D57-A083F23F6937Q37964507-F65A4EB2-1D6D-4814-9E21-687663649E14Q38044750-3CDAABB9-DD1A-46D8-991E-EB94C922C3D7
P2860
IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@en
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@nl
type
label
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@en
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@nl
prefLabel
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@en
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@nl
P2093
P1476
IL-8/CXCL8 and growth-related ...... hypertrophic differentiation.
@en
P2093
Denise Merz
Robert Terkeltaub
P304
P356
10.4049/JIMMUNOL.171.8.4406
P407
P577
2003-10-01T00:00:00Z